| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8215696 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 7 Pages |
Abstract
Sorafenib increased tumor hypoxia, raising concern that it might impair rather than improve disease control when added to RTCT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Michael F. MD, Carol A. MD, Naz PhD, Blaise MD, Melania MSc, Stacy BMSc, Rachel BMSc, Masoom MD, Sunmo PhD, Helen MD, Ivan PhD, Richard P. PhD, Anthony MD, Amit M. MD,